Baltimore, WV
Peptide Therapy clinics in Baltimore
Baltimore has a Johns Hopkins-adjacent academic medicine culture and full NP practice authority, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across Harbor East, Mount Vernon, Towson, and Federal Hill range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the Johns Hopkins, University of Maryland, and MedStar network. The scene here skews toward academic-affiliated physicians running longevity practices with conservative protocols. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Baltimore clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.
No clinics found
Reset all filtersRegulatory context
A note on West Virginia's peptide therapy rules.
Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. In 2023 and 2024 the FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list, which restricts 503A compounding pharmacies from sourcing those ingredients for patient-specific prescriptions. Section 503A covers traditional pharmacies; Section 503B covers FDA-registered outsourcing facilities operating under cGMP.
-
West Virginia Pharmacy Practice Act (W. Va. Code Chapter 30 Article 5)
Governs compounding, licensure, and sourcing under the West Virginia Board of Pharmacy. -
West Virginia Medical Practice Act (W. Va. Code Chapter 30 Article 3)
Defines the practice of medicine and limits who may prescribe or administer compounded injectables. -
West Virginia Board of Examiners for Registered Professional Nurses Rules
Defines RN and APRN scope for administration of injectable preparations.
The West Virginia Board of Pharmacy inspects sterile compounding facilities and has taken action against unlicensed and non-compliant compounding operations. Non-resident pharmacies shipping into West Virginia must hold a current non-resident permit. Clinics dispensing from in-office stock of compounded peptides are reviewed for compliance with office-use rules. Enforcement is reactive and complaint-driven.
Peptide Therapy in Baltimore, answered.
Explore related care